Neuroprotection of edaravone on hypoxic-ischemic brain injury in neonatal rats

Brain Res Dev Brain Res. 2004 Jul 19;151(1-2):129-39. doi: 10.1016/j.devbrainres.2004.04.006.

Abstract

Edaravone has an inhibitory effect on lipid peroxidation by scavenging free radicals and prevents vascular endothelial cell injury. We examined whether edaravone was effective on hypoxic-ischemic (HI) brain injury in immature brain or not using the Rice-Vannucci model. The initial dose, 3 mg/kg (0.05 ml) of edaravone, was injected intraperitoneally just before hypoxic exposure. Subsequently, the same dose was injected every 12 h until the animals were killed. Controls received saline injection as the same protocol. Macroscopic evaluation of brain injury revealed that the neuroprotective effect of edaravone on HI brain after 48 h post HI. TUNEL showed that edaravone injection decreased neurodegeneration. Quantitative analysis of cell death using H&E-stained 2.5 microm sections showed that there was a trend for both necrotic and apoptotic cells to decrease in edaravone injection group. Edaravone injection inhibited the release of cytochrome c from mitochondria to cytosol and caspase-3 activation in cortex and hippocampus between 24 and 168 h post HI. Our results suggest that edaravone is protective after HI insult in the immature brain by decreasing both apoptosis and necrosis and also by inhibiting mitochondrial injury.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Animals, Newborn
  • Antipyrine / analogs & derivatives*
  • Antipyrine / therapeutic use*
  • Blotting, Western / methods
  • Brain / growth & development*
  • Brain / metabolism
  • Brain / pathology
  • Caspase 3
  • Caspases / metabolism
  • Cell Count / methods
  • Cell Death / physiology
  • Cytochromes c / metabolism
  • DNA Fragmentation / drug effects
  • Edaravone
  • Hypoxia-Ischemia, Brain / prevention & control*
  • In Situ Nick-End Labeling / methods
  • Neurons / drug effects
  • Neurons / metabolism
  • Neurons / pathology
  • Neuroprotective Agents / therapeutic use*
  • Rats
  • Time Factors

Substances

  • Neuroprotective Agents
  • Cytochromes c
  • Casp3 protein, rat
  • Caspase 3
  • Caspases
  • Edaravone
  • Antipyrine